Perfluoroalkyl substances and beta cell deficient diabetes
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Aims Perfluoroalkyl Substances (PFAS) are synthetic hydrocarbons shown to preserve pancreatic islet cell viability and reduce islet cell hypoxia and apoptosis. We investigated the relationship of serum PFAS with diabetes, and whether this varied by diabetes type. Methods 6,460 individuals with and 60,439 without diabetes from the C8 Health Project, were categorized into three groups: Type 1 (n=820), Type 2 (n=4,291), or Uncategorized diabetes (n=1,349, missing data on diabetes type or diabetes based on blood sugar at study entry). Four PFAS were investigated: perfluorohexane sulfonate (PFHxS), perfluoroctanoic acid (PFOA), perfluoroctane sulfonate (PFOS), and perfluorononaoic acid (PFNA). Results PFAS levels were significantly lower in those with diabetes, and lowest in those with Type 1 diabetes. In age and sex adjusted analyses, ORs (CI) for Type 1, Type 2, and Uncategorized diabetes compared to no diabetes were 0.59 (0.54–0.64), 0.74 (0.71–0.77), 0.84 (0.78–0.90) respectively for PFHxS; 0.69 (0.65–0.74), 0.87 (0.89–0.91), 0.92 (0.88–0.97) respectively for PFOA; 0.65 (0.61–0.70), 0.86 (0.82–0.90), 0.93 (0.86–1.03) respectively for PFOS; and 0.65 (0.57–0.74), 0.94 (0.88–1.00), 0.95 (0.85–1.06), respectively for PFNA. Further adjustment for eGFR and other covariates did not eliminate these inverse associations. Conclusions PFAS levels were negatively associated with diabetes. This inverse relationship was strongest for Type 1 diabetes, suggesting the relationship with serum PFAS may vary with the severity of islet cell deficiency.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Perfluoroalkyl Acids: A Review of Monitoring and Toxicological Findings
Lau, C., Anitole, K., Hodes, C., Lai, D., Pfahles-Hutchens, A., & Seed, J. (2007) · Toxicological Sciences · doi:10.1093/toxsci/kfm128 · Cited by 2,620 · cited 8×
“PFAS.[1] We have shown that PFAS, specifically the long chain length perfluoroalkyl substances PFHxS, PFOA, PFOS, and PFNA are associated with a reduced odds of having diabetes, with the strongest association observed in both children and adults with Type 1 diabetes.”
InfluentialThe toxicology of perfluorooctanoate
Kennedy, G. L., Butenhoff, J. L., Olsen, G. W., O'Connor, J. C., Seacat, A. M., Perkins, R. G., Biegel, L. B., Murphy, S. R., & Farrar, D. G. (2004) · Critical Reviews in Toxicology · doi:10.1080/10408440490464705 · Cited by 742
Melzer, D., Rice, N., Depledge, M. H., Henley, W. E., & Galloway, T. S. (2010) · Environmental Health Perspectives · doi:10.1289/ehp.0901584 · Cited by 496
Steenland, K., Tinker, S., Shankar, A., & Ducatman, A. (2010) · Environmental Health Perspectives · doi:10.1289/ehp.0900940 · Cited by 224 · cited 1×
“Estimated participation rate in the C8 Health Project among adult residents of the affected water districts was 81%.[19] Data from the C8 Health Project (n=69,030) was obtained for use in the current study.”
Circulating levels of perfluoroalkyl substances and prevalent diabetes in the elderly
Lind, L., Zethelius, B., Salihovic, S., van Bavel, B., & Lind, P. M. (2014) · Diabetologia · doi:10.1007/s00125-013-3126-3 · Cited by 128
Cited by
Endocrine-disrupting chemicals: Implications for human health
Kahn, L. G., Philippat, C., Nakayama, S. F., Slama, R., & Trasande, L. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30129-7 · Cited by 797
Meneguzzi, A., Fava, C., Castelli, M., & Minuz, P. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.706352 · Cited by 174
“Conway and colleagues, examining 6,460 individuals with and 60,439 without diabetes mellitus from the C8 Health Project, found that PFAS levels were significantly lower in those with type 1 and type 2 diabetes, with similar results for PFHxS, PFOA, PFOS and PFNA (47, 48).”
ResultYu, G., Jin, M., Huang, Y., Aimuzi, R., Zheng, T., Nian, M., Tian, Y., Wang, W., Luo, Z., Shen, L., et al. (2021) · Environment International · doi:10.1016/j.envint.2021.106621 · Cited by 141
Perfluoroalkyl substances and risk of type II diabetes: A prospective nested case-control study
Donat-Vargas, C., Bergdahl, I. A., Tornevi, A., Wennberg, M., Sommar, J., Kiviranta, H., Koponen, J., Rolandsson, O., & Åkesson, A. (2019) · Environment International · doi:10.1016/j.envint.2018.12.026 · Cited by 88
Exposure to per- and polyfluoroalkyl substances (PFAS) and type 2 diabetes risk
Roth, K., & Petriello, M. C. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.965384 · Cited by 78
Metadata
- Authors
- Conway, B., Innes, K. E., & Long, D.
- Venue
- Journal of Diabetes and its Complications
- Publisher
- Elsevier BV
- Published
- 2016-08
- Volume
- 30
- Issue
- 6
- Pages
- 993-998
- ISSN
- 0891-6632 (ISSN-L)
- 1056-8727
- OpenAlex
- W2345339254
- Cited by
- 75
- References
- 5
- FWCI
- 3.29
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Perfluoroalkyl substances and beta cell deficient diabetes. https://app.cochat.ai/papers/10.1016/j.jdiacomp.2016.05.001
- The paper
- Conway, B., Innes, K. E., & Long, D. (2016). Perfluoroalkyl substances and beta cell deficient diabetes. Journal of Diabetes and its Complications. https://doi.org/10.1016/j.jdiacomp.2016.05.001
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.